MD 3271 | 2015
Medical Devices
TUMOR ABLATION MARKET BY PROCEDURE VOLUME, TECHNOLOGY (RF, MICROWAVE, CRYOABLATION, OTHERS), MODE OF TREATMENT (PERCUTANEOUS, LAPAROSCOPIC, SURGICAL), APPLICATION (LIVER CANCER, LUNG CANCER, KIDNEY CANCER, BONE METASTASIS)
– GLOBAL FORECASTS TO 2019 Report Description
Table of Contents List of Tables Sample Tables Related Reports
MarketsandMarkets North - Dominion Plaza, 17304, Preston Road, Suite 800, Dallas, TX 75252, U.S. Tel. No.: 1-888-600-6441 Email: sales@marketsandmarkets.com Website: www.marketsandmarkets.com
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers fourteen industry verticals, including aerospace and defence, advanced materials, automotives and transportation, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
Copyright Š 2015 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets.
2 Š MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
REPORT DESCRIPTION The global tumor ablation market is poised to grow at a CAGR of XX% during 2014-2019, and is expected to reach a value of ~XX Million in 2019. Although the mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the tumor ablation market, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period. The growth of the tumor ablation market is driven by factors such as growing geriatric population, coupled with an increasing population base of cancer patients, technological advancements to support new product development, increasing demand for minimally invasive cancer treatment procedures, growing awareness about ablation procedures over conventional therapeutic and surgical procedures, and rising number of hospitals and surgical centers. However, factors such as costcontainment measures taken by various governments and ongoing healthcare reforms in the U.S. are restraining the growth of this market. Therapeutic challenges related to ablation procedures and stringent regulatory guidelines leading to significant increase in gestation period of product launches is posing a significant challenge for the growth of the tumor ablation market. In this report, the global tumor ablation market has been segmented on the basis of type of technology (radiofrequency, microwave, cryoablation, and other technologies), mode of treatment (percutaneous ablation, laparoscopic ablation, surgical ablation), and type of application (liver cancer, lung cancer, kidney cancer, bone metastasis, and others). The radiofrequency ablation technology segment accounted for the largest share of the global tumor ablation market in 2014, followed by the microwave ablation technology market. Factors such as significant awareness regarding application of radiofrequency ablation in cancer treatment, presence of large number of radiofrequency ablation centers across the region, and low procedural cost associated with radiofrequency tumor ablation are driving the growth of tumor ablation market. Geographically, North America (comprising the U.S. and Canada) commands the largest share of the global tumor ablation market in 2014, followed by Europe. The tumor ablation market in the North America is primarily driven by factors such as presence of large number of ablation centers, increasing installation base of advanced tumor ablation devices, increasing demand for minimally invasive cancer treatment procedures, and growing awareness about ablation procedures over conventional therapeutic and surgical procedures. However, financial constraints faced by market players are limiting the growth of the tumor ablation market in this region. The Asia-Pacific region is poised to grow at the highest CAGR during next five years, owing to factors such as large patient population base, growing government support to increase public access for advanced therapeutic and surgical procedures, and strengthening healthcare infrastructure across the region. The global tumor ablation market is moderately competitive with a various global as well as local market players. As of 2013, the global tumor ablation market was dominated by AngioDynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic, Inc. (U.S.), CONMED Corporation (U.S.), and Smith & Nephews Plc (U.K.), which together accounted for ~XX% of the market. New product launches, partnerships, agreements, and collaborations, and strategic acquisitions are the major strategies adopted by most of the market players to achieve growth in the global tumor ablation market.
Reasons to Buy the Report: From an insight perspective, this research report has focused on various levels of analysis — industry analysis (industry trends and Porter’s five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the tumor ablation market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.
3 © MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271 The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share. The report provides insights on the following pointers:
Market Penetration: Comprehensive information on tumor ablation products offered by the top 10 players in the global tumor ablation market. The report analyzes the tumor ablation market by type of technology, department, and application across key geographic region
Product Development/Innovation: Detailed insights on upcoming tumor ablation technologies, research and development activities, and new product launches in the global tumor ablation market
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various tumor ablation products across key geographic region
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global tumor ablation market
Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global tumor ablation market
4 © MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
1
RESEACH METHODOLOGY
1.1
RESEARCH DATA
This research study involved the usage of extensive secondary sources, directories, and databases—such as Hoovers, Bloomberg Business-week, Factiva, and One-Source along with government databases —to identify and collect information useful for this technology-based, market-oriented, and commercial study of the global tumor ablation market. In-depth interviews were conducted from various primary respondents that mainly include key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure shows the market research methodology applied in making this report.
FIGURE 1
RESEARCH DESIGN
HISTORICAL DATA FOR THE ORTHODONTIC SUPPLIES MARKET
INFLUENCING FACTORS (Market Trends and Dynamics)
Evolution
Pricing Trends
Reimbursement Scenario
Regulatory Landscape
Market Share
Competitive Landscape
Supply & Value Chain
PEST Analysis & Geographic Usage Pattern
Market Drivers:
Market Restraints:
Market Opportunities:
XX
XX
XX
XX
XX
XX
XX
XX
XX
Burning Issues:
Winning Imperatives:
Industry Trends:
XX
XX
XX
XX
XX
XX
XX
XX
XX
• Agreements, Collaborations, & Partnerships: More than 20 deals in the last three years • New Product Launches: More than 20 new product launches in the last three years Historical Data of the Market
Market Size & Forecast by Product
Impact Analysis of Market Trends
Market Size & Forecast by Geography
Geographic Analysis
Arrive at the Market Size, Share, and CAGR for the Market
5 © MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
1.1.1
SECONDARY DATA
The secondary sources referred to for this research study include publications from government sources; corporate filings (such as annual reports, investor presentations, and financial statements); research journals; and trade, business, and professional associations; among others. Secondary research was mainly used to obtain key information about the industry’s total pool of key players, market classification and segmentation according to industry trends to the bottom-most segment level, global market trends, and key developments by both public and private organizations.
Secondary sources
Parameter
1
Market Size of tumor ablation products in North America, Europe, and Asia-Pacific regions
Company Financials Magazines Journals Press Releases Paid Databases MarketsandMarkets Data Repository
2
Revenue of Companies
Annual Reports and SEC Filings Company Websites Public Databases MarketsandMarkets Data Repository
Company Websites Annual Reports and SEC Filings Press Releases MarketsandMarkets Data Repository
3
1.2
Qualitative Information (Market Dynamics and Trends)
MARKET SIZE ESTIMATION
Both, top-down and bottom-up approaches were used to estimate and validate the size of the global tumor ablation market, and to estimate the size of various other dependent submarkets in the overall market. This entire research methodology includes the study of the annual and financial reports of the top market players, as well as interviews with industry experts (such as CEOs, VPs, directors, and marketing executives) for the key insights (both quantitative and qualitative) on the market. All percentage shares, splits, and breakdowns were determined by using secondary sources, and were verified through primary sources. The key players in the market were identified through secondary research, and their market shares were determined through primary and secondary research. All the market influencing parameters have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and analysis from MarketsandMarkets, and presented in this report. Market shares were then estimated for top companies to verify the total market revenue arrived earlier in the bottom-up approach. With the data triangulation procedure and validation of data through primaries, the exact values of the overall parent market size and each individual market size were determined and confirmed in this study. The data triangulation procedure implemented for this study is explained in the next section.
6 © MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
1.3
MARKET BREAKDOWN AND DATA TRIANGULATION
After arriving at the overall market size from the market size estimation process explained above, the total market was split into several segments and sub-segments. In order to complete the overall market engineering process and to arrive at the exact statistics for all the segments and sub-segments, the data triangulation and market breakdown procedure was employed wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market was validated using both top-down and bottom-up approaches.
1.3.1
BOTTOM-UP APPROACH Bottom-up Approach (Segmental Analysis)
Global Market Value
Total Market Size ($Million) = Americas (Volume of product segment 1 x ASP) + Europe (Volume of product segment 2 x ASP) + …
Summation of A x B of all Regions
Average Selling Price (ASP) per Region for Each Type of Product Segment (B)
Primary: Demand & Supply Side Experts Secondary: Annual Reports, Presentations, Press Releases, Journals, Paid Databases, and MarketsandMarkets Repository
Geographical Split to the Number of Units Sold (A)
Number of Units Sold for Each Product Segment, Globally
1.3.2
Primary: Demand and Supply Side Experts Secondary: Annual Reports, Presentations, Press Release, Journals, Paid Databases, and MarketsandMarkets Repository
TOP-DOWN APPROACH Top-down Approach (Segmental Analysis) Total Global Tumor Ablation Market ($Million)
Global Tumor Ablation Market The Global Market Size is Validated Through Primaries (Demand and Supply Side Experts)
Secondary: Annual Reports, SEC Filings, Investors Percentage Splits for the Subsegments of the Tumor Ablation Market
Regional Split
Presentations, Press Releases, Journals, Paid Databases, and MarketsandMarkets Repository Primary: Demand and Supply Side Experts
Primary: Demand and Supply Side Experts Secondary: Annual Reports, SEC Filings, Investors Presentations, Company Websites, Press Releases, and News Articles
Regional Market for Each Subsegment
Secondary: Annual Reports, SEC Filings, Investors Presentations, Press Releases, Journals, Paid Databases, and MarketsandMarkets Repository Primary: Demand and Supply Side Experts
7 © MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
1.4
PRIMARY DATA
An extensive primary research has been conducted after acquiring knowledge about market scenario through secondary research. More than 90 primary interviews were conducted from both demand and supply side. The primaries interviewed for this study included experts in tumor ablation industry. These industry experts were CEOs, VPs, directors, sales head, and marketing managers of the tier I, II, and III companies engaged in offering tumor ablation products across the globe, and administrators and purchase managers of organizations from demand side. Approximately XX% and XX% primary interviews were conducted from both demand and supply side, respectively. This primary data was collected through questionnaires, mails, and telephonic interviews.
1.4.1
BREAKDOWN OF PRIMARIES
FIGURE 2
BREAK DOWN OF SUPPLY SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & REGION
NUMBER OF PRIMARIES: BY COMPANY TYPE
NUMBER OF PRIMARIES: BY DESIGNATION
NUMBER OF PRIMARIES: BY REGION
x%
xx% xx%
xx%
Tier 1 Companies
xx%
xx%
xx%
xx%
Xx%
Tier 2 Companies
C Level
Director Level
xx%
North America
Europe
Asia-Pacific
ROW
Others
Tier 3 Companies
Note 1: *Others include sales managers, marketing managers, and product managers Note 2: The tier of the companies is defined on the basis of their total revenue, as of 2014: Tier 1 = >$xx million, Tier 2 = $xx million to $xx million and Tier 3 = <$xx million
8 © MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
TABLE OF CONTENTS 1
2
INTRODUCTION 1.1
OBJECTIVES OF THE STUDY
1.2
MARKET DEFINITION
1.3
MARKET SCOPE 1.3.1
MARKETS COVERED
1.3.2
GEOGRAPHIC SCOPE
1.3.3
YEARS CONSIDERED FOR THE STUDY
1.4
LIMITATIONS
1.5
MARKET STAKEHOLDERS
RESEARCH METHODOLOGY 2.1
RESEARCH DATA 2.1.1
SECONDARY DATA 2.1.1.1
2.1.2
2.2
2.3
3
Key data from secondary sources
PRIMARY DATA 2.1.2.1
Key data from primary sources
2.1.2.2
Key industry insights
2.1.2.3
Breakdown of primaries
FACTOR ANALYSIS 2.2.1
INTRODUCTION
2.2.2
DEMAND-SIDE ANALYSIS
2.2.3
SUPPLY-SIDE ANALYSIS
MARKET SIZE ESTIMATION 2.3.1
TOP-DOWN APPROACH
2.3.2
BOTTOM-UP APPROACH
2.4
MARKET BREAKDOWN AND DATA TRIANGULATION
2.5
RESEARCH ASSUMPTIONS
EXECUTIVE SUMMARY 3.1
INTRODUCTION
3.2
HISTORY, EVOLUTION, AND CURRENT SCENARIO
3.3
FUTURE OUTLOOK
3.4
CONCLUSION
4
PREMIUM INSIGHTS
5
MARKET OVERVIEW 5.1
INTRODUCTION
5.2
MARKET SEGMENTATION 9
© MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
6
7
5.2.1
MARKET, BY TECHNOLOGY
5.2.2
MARKET, BY MODE OF TREATMENT
5.3.3
MARKET, BY APPLICATION
5.3
MARKET EVOLUTION
5.4
MARKET DYNAMICS 5.4.1
KEY MARKET DRIVERS
5.4.2
KEY MARKET RESTRAINTS
5.4.3
KEY MARKET OPPORTUNITIES
5.4.4
KEY MARKET CHALLENGES
INDUSTRY INSIGHTS 6.1
INTRODUCTION
6.2
VALUE CHAIN ANALYSIS
6.3
INDUSTRY TRENDS
6.4
PORTER'S FIVE FORCES ANALYSIS 6.4.1
THREAT FROM NEW ENTRANTS
6.4.2
THREAT FROM SUBSTITUTES
6.4.3
BARGAINING POWER OF SUPPLIERS
6.4.4
BARGAINING POWER OF BUYERS
6.4.5
INTENSITY OF COMPETITIVE RIVALRY
TUMOR ABLATION MARKET, BY TECHNOLOGY 7.1
INTRODUCTION
7.2
RADIOFREQUENCY (RF) ABLATION 7.2.1
7.3
MICROWAVE ABLATION 7.3.1
7.4
MARKET, BY APPLICATION
OTHER TECHNOLOGIES* 7.5.1
8
MARKET, BY APPLICATION
CRYOABLATION 7.4.1
7.5
MARKET, BY APPLICATION
MARKET, BY APPLICATION
TUMOR ABLATION MARKET, BY MODE OF TREATMENT 8.1
INTRODUCTION
8.2
PERCUTANEOUS ABLATION 8.2.1
8.3
LAPAROSCOPIC ABLATION 8.3.1
8.4
MARKET, BY APPLICATION MARKET, BY APPLICATION
SURGICAL ABLATION 8.4.1
MARKET, BY APPLICATION
10 © MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
9
TUMOR ABLATION MARKET, BY APPLICATION 9.1
INTRODUCTION
9.2
LIVER CANCER
9.3
9.4
9.5
9.6
9.2.1
MARKET, BY TECHNOLOGY
9.2.2
MARKET, BY PROCEDURE VOLUME
LUNG CANCER 9.3.1
MARKET, BY TECHNOLOGY
9.3.2
MARKET, BY PROCEDURE VOLUME
KIDNEY CANCER 9.4.1
MARKET, BY TECHNOLOGY
9.4.2
MARKET, BY PROCEDURE VOLUME
BONE METASTASIS 9.5.1
MARKET, BY TECHNOLOGY
9.5.2
MARKET, BY PROCEDURE VOLUME
OTHERS** 9.6.1
MARKET, BY TECHNOLOGY
10 TUMOR ABLATION MARKET, BY REGION 10.1
INTRODUCTION
10.2
NORTH AMERICA
10.3
10.4
10.5
10.2.1
U.S.
10.2.2
CANADA
EUROPE 10.3.1
ITALY
10.3.2
GERMANY
10.3.3
FRANCE
10.3.4
U.K.
10.3.5
SPAIN
10.3.6
REST OF EUROPE
ASIA-PACIFIC 10.4.1
JAPAN
10.4.2
CHINA
10.4.3
INDIA
10.4.4
REST OF ASIA-PACIFIC
REST OF THE WORLD (ROW)
11 COMPETITIVE LANDSCAPE 11.1
INTRODUCTION
11.2
MARKET SHARE ANALYSIS, BY KEY PLAYERS
11.3
COMPETITIVE SCENARIO
11.4
RECENT DEVELOPMENTS 11.4.1
NEW PRODUCTS LAUNCHES AND PRODUCT ENHANCEMENTS 11
© MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271 11.4.2
AGREEMENTS, PARTNERSHIPS, AND AGREEMENTS
11.4.3
MERGERS AND ACQUISITIONS
11.4.4
GEOGRAPHIC EXPANSIONS
11.4.5
OTHER DEVELOPMENTS
12 COMPNY PROFILES*** 12.1
INTRODUCTION
12.2
ANGIODYNAMICS, INC. 13.2.1
BUSINESS OVERVIEW****
13.2.2
FINANCIAL OVERVIEW
13.2.3
PRODUCT PORTFOLIO
13.2.4
KEY STRATEGIES
13.2.5
RECENT DEVELOPMENTS
12.3
BOSTON SCIENTIFIC CORPORATION
12.4
COVIDIEN, PLC
12.5
GALIL MEDICAL, INC.
12.6
HEALTHTRONICS, INC.
12.7
MERMAID MEDICAL
12.8
MEDTRONIC, INC.
12.9
CONMED CORPORATION
12.10
OLYMPUS CORPORATION
12.11
SMITH & NEPHEWS PLC
13 APPENDIX 13.1
INSIGHTS FROM INDUSTRY EXPERTS
13.2
DISCUSSION GUIDE
13.3
INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
13.4
AVAILABLE CUSTOMIZATIONS
13.5
RELATED REPORTS
*Other Technologies include irreversible electroporation (IRE), Radio-Iodine, HIFU, and Laser Ablation **Others include cancer of prostate, breast, colorectal, neuroendocrine, head, neck, and lumbar vertebrae ***The list of top ten leading companies in the market could change with the progress of market study ****Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 © MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
LIST OF TABLES U
TABLE 1
GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 2
TUMOR ABLATION MARKET SIZE FOR RADIOFREQUENCY ABLATION TECHNOLOGY, BY REGION, 2012-2019 ($MILLION)
TABLE 3
TUMOR ABLATION MARKET SIZE FOR MICROWAVE ABLATION TECHNOLOGY, BY REGION, 2012-2019 ($MILLION)
TABLE 4
TUMOR ABLATION MARKET SIZE FOR CRYOABLATION TECHNOLOGY, BY REGION, 2012-2019 ($MILLION)
TABLE 5
TUMOR ABLATION MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 20122019 ($MILLION)
TABLE 6
GLOBAL TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 7
TUMOR ABLATION MARKET SIZE FOR PERCUTANEOUS ABLATION TREATMENT, BY REGION, 2012-2019 ($MILLION)
TABLE 8
TUMOR ABLATION MARKET SIZE FOR LAPAROSCOPIC ABLATION TREATMENT, BY REGION, 2012-2019 ($MILLION)
TABLE 9
TUMOR ABLATION MARKET SIZE FOR SURGICAL ABLATION TREATMENT, BY REGION, 2012-2019 ($MILLION)
TABLE 10
GLOBAL TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 11
GLOBAL TUMOR ABLATION PROCEDURE VOLUME, BY APPLICATION, 2012-2019
TABLE 12
TUMOR ABLATION MARKET SIZE FOR LIVER CANCER APPLICATION, BY REGION, 2012-2019 ($MILLION)
TABLE 13
TUMOR ABLATION PROCEDURE VOLUME FOR LIVER CANCER APPLICATION, BY REGION, 2012-2019
TABLE 14
TUMOR ABLATION MARKET SIZE FOR LUNG CANCER APPLICATION, BY REGION, 2012-2019 ($MILLION)
TABLE 15
TUMOR ABLATION PROCEDURE VOLUME FOR LUNG CANCER APPLICATION, BY REGION, 2012-2019
TABLE 16
TUMOR ABLATION MARKET SIZE FOR KIDNEY CANCER APPLICATION, BY REGION, 2012-2019 ($MILLION)
TABLE 17
TUMOR ABLATION PROCEDURE VOLUME FOR KIDNEY CANCER APPLICATION, BY REGION, 2012-2019
TABLE 18
TUMOR ABLATION MARKET SIZE FOR BONE METASTASIS APPLICATION, BY REGION, 2012-2019 ($MILLION)
TABLE 19
TUMOR ABLATION PROCEDURE VOLUME FOR BONE METASTASIS APPLICATION, BY REGION, 2012-2019
TABLE 20
TUMOR ABLATION MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 20122019 ($MILLION)
TABLE 21
TUMOR ABLATION MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 22
TUMOR ABLATION PROCEDURE VOLUME, BY REGION, 2012-2019
TABLE 23
NORTH AMERICAN TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
13 © MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271 TABLE 24
NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 25
NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 26
NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 27
NORTH AMERICAN TUMOR ABLATION PROCEDURE VOLUME, BY APPLICATION, 2012-2019
TABLE 28
U.S.: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 29
U.S.: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 30
U.S.: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 31
CANADA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 32
CANADA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 33
CANADA: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 34
EUROPEAN TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
TABLE 35
EUROPE: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 36
EUROPE: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 37
EUROPE: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 38
EUROPEAN TUMOR ABLATION PROCEDURE VOLUME, BY APPLICATION, 20122019
TABLE 39
ITALY: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 40
ITALY: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 41
ITALY: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 42
GERMANY: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 43
GERMANY: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 20122019 ($MILLION)
TABLE 44
GERMANY: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 45
FRANCE: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 46
FRANCE: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 47
FRANCE: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 48
U.K.: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 49
U.K.: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 50
U.K.: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 51
SPAIN: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 14
© MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271 TABLE 52
SPAIN: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION
TABLE 53
SPAIN: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 54
REST OF EUROPE: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 55
REST OF EUROPE: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 56
REST OF EUROPE: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 57
ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
TABLE 58
ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 59
ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 20122019 ($MILLION)
TABLE 60
ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 61
ASIA-PACIFIC TUMOR ABLATION PROCEDURE VOLUME, BY APPLICATION, 20122019
TABLE 62
JAPAN: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 63
JAPAN: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 64
JAPAN: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 65
CHINA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 66
CHINA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 67
CHINA: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 68
INDIA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 69
INDIA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 70
INDIA: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 71
REST OF ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 20122019 ($MILLION)
TABLE 72
REST OF ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 73
REST OF ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 20122019 ($MILLION)
TABLE 74
ROW: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 75
ROW: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2012-2019 ($MILLION)
TABLE 76
ROW: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 77
TOP 5 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2012–2014
TABLE 78
TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012–2014
TABLE 79
TOP 5 GEOGRAPHICAL EXPANSIONS, 2012–2014
TABLE 80
TOP 5 MERGERS AND ACQUISITIONS, 2012–2014
TABLE 81
TOP 5 OTHER DEVELOPMENTS, 2012–2014
15 © MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
LIST OF FIGURES FIGURE 1
RESEARCH DESIGN
FIGURE 2
HEALTHCARE EXPENDITURE ACROSS KEY MARKETS: 2000 VS. 2012
FIGURE 3
HEALTHCARE SPENDING MATRIX: KEY MARKETS (2012)
FIGURE 4
GLOBAL RISE IN PROPORTION OF GERIATRIC POPULATION (2000 - 2013)
FIGURE 5
INCREASE IN AGING POPULATION, BY COUNTRY (2005 VS. 2010)
FIGURE 6
GLOBAL BURDEN OF CANCER, BY REGION – 2005 TO 2030
FIGURE 7
RISING INCIDENCE OF CANCER ACROSS KEY REGIONS: 2008 VS. 2012
FIGURE 8
GROWING PREVALENCE OF CANCER ACROSS KEY MARKETS, 2012
FIGURE 9
ANNUAL TUMOR ABLATION PROCEDURES ACROSS KEY GLOBAL MARKETS (2012)
FIGURE 10
NUMBER OF NEW PRODUCT LAUNCHES: TUMOR ABLATION VS. OTHER APPLICATIONS , 2012–2014
FIGURE 11
TUMOR ABLATION VS. PARENT MARKET: A COMPARATIVE STUDY
FIGURE 12
TOP-DOWN APPROACH
FIGURE 13
BOTTOM-UP APPROACH
FIGURE 14
DATA TRIANGULATION
FIGURE 15
ASSUMPTIONS OF THE RESEARCH STUDY
FIGURE 16
TUMOR ABLATION MARKET, BY TYPE (2014): MICROWAVE ABLATION MARKET TO GROW AT THE HIGHEST RATE IN THE FORECAST PERIOD
FIGURE 17
TUMOR ABLATION TECHNOLOGIES MARKET, BY APPLICATION (2014)
FIGURE 18
TUMOR ABLATION MARKET SHARE, BY REGION (2014): ASIA-PACIFIC TO OFFER HIGH GROWTH OPPORTUNITIES TO MARKET PLAYERS
FIGURE 19
ATTRACTIVE GROWTH OPPORTUNITIES IN THE TUMOR ABLATION TECHNOLOGIES MARKET
FIGURE 20
NORTH AMERICA COMMANDS THE LARGEST SHARE OF THE RF ABLATION TECHNOLOGIES MARKET IN 2014
FIGURE 21
DEVELOPING MARKETS TO GROW TWICE AS FAST AS DEVELOPED ONES
FIGURE 22
DEMAND FOR TUMOR ABLATION IS ESTIMATED TO INCREASE RAPIDLY FOR LUNG AND KIDNEY CANCER ABLATION TREATMENTS
FIGURE 23
RISING PREVALENCE OF CANCER WILL SPUR THE DEMAND FOR TUMOR ABLATION PROCEDURES
FIGURE 24
WORLDWIDE PREVALENCE OF CANCER: 2014 VS. 2020
FIGURE 25
GLOBAL DISTRIBUTION OF CANCER MORTILITY RATES AMONG MALES, 2011
FIGURE 26
GLOBAL DISTRIBUTION OF CANCER MORTALITY RATES AMONG FEMALES, 2011
FIGURE 27
INCREASINGLY AGING POPULATION ACROSS MAJOR AND EMERGING NATIONS (2012 VS 2020)
FIGURE 28
PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE—DEVELOPED VS. DEVELOPING COUNTRIES (2010-2012)
FIGURE 29
VALUE CHANGE ANALYSIS (2013): MAJOR VALUE IS ADDED DURING MANUFACTURING PHASE
FIGURE 30
PRESENCE OF LARGE NUMBER OF NEW ENTRANTS INCREASES MARKET COMPETITION
FIGURE 31
MICROWAVE ABLATION SEGMENT TO GROW THE FASTEST AMONG ALL TECHNOGIES IN TUMOR ABLATION MARKET 16
© MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271 FIGURE 32
NORTH AMERICA WILL CONTINUE TO DOMINATE THE RADIOFREQUENCY TUMOR TECHNOLOGIES MARKET FOR NEXT FIVE YEARS
FIGURE 33
NORTH AMERICA IS EXPECTED TO COVER NEARLY HALF OF THE TUMOR CRYOABLATION MARKET IN 2014
FIGURE 34
ASIA-PACIFIC MARKET OF TUMOR ABLATION PRODUCTS TO GROW THE FASTEST FOR LAPAROSCOPIC ABLATION TREATMENT SEGMENT
FIGURE 35
MARKET SHARE OF SURGICAL ABLATION TREATMENT SEGMENT TO GROW THE HIGHEST AMONG TOTAL ABLATION PROCEDURES
FIGURE 36
LIVER CANCER ABLATION MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORCAST PERIOD
FIGURE 37
RISING INCIDENCE OF CANCER IN THE ASIAN REGION IS AUGMENTING THE MARKET GROWTH FOR TUMOR ABLATION DEVICES
FIGURE 38
MARKET SHARE BY KEY ABLATION TECHNOLOGIES IN LIVER CANCER ABLATION PROCEDURES (2014)
FIGURE 39
MARKET SHARE BY KEY ABLATION TECHNOLOGIES IN LUNG CANCER ABLATION PROCEDURES (2014)
FIGURE 40
MARKET SHARE BY KEY ABLATION TECHNOLOGIES IN BONE METASTASIS ABLATION PROCEDURES (2014)
FIGURE 41
GEOGRAPHIC SNAPSHOT (2014): RAPIDLY GROWING MARKETS ARE EMERGING AS NEW HOT SPOTS
FIGURE 42
NORTH AMERICA TUMOR ABLATION MARKET: DEMAND WILL BE DRIVEN BY HIGH PREVALENCE OF CANCERS
FIGURE 43
ITALY IS EXPECTED TO COMMANT THE MAJOR SHARE OF EUROPEAN TUMOR ABLATION MARKET IN 2014
FIGURE 44
ASIA-PACIFIC TUMOR ABLATION MARKET SNAP SHOT (2014): CHINA IS THE MOST LUCRATIVE MARKET
FIGURE 45
GLOBAL TUMOR ABLATION MARKET SHARE, BY KEY PLAYER, 2013
FIGURE 46
STRATEGIC BENCHMARKING: LEADING COMPANIES FOCUS ON TECHNOLOGICAL ADVANCEMENTS TO STRENGTHEN THEIR MARKET POSITION
FIGURE 47
GEOGRAPHIC REVENUE MIX OF THE TOP FIVE PLAYERS
FIGURE 48
ANGIODYNAMICS, INC. : COMPANY SNAPSHOT
FIGURE 49
BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 50
COVIDIEN, PLC : COMPANY SNAPSHOT
FIGURE 51
GALIL MEDICAL, INC.: COMPANY SNAPSHOT
FIGURE 52
HEALTHTRONICS, INC.: COMPANY SNAPSHOT
FIGURE 53
MERMAID MEDICAL: COMPANY SNAPSHOT
FIGURE 54
MEDTRONIC, INC. : COMPANY SNAPSHOT
FIGURE 55
CONMED CORPORATION : COMPANY SNAPSHOT
FIGURE 56
OLYMPUS CORPORATION : COMPANY SNAPSHOT
FIGURE 57
SMITH & NEPHEWS PLC : COMPANY SNAPSHOT
17 © MarketsandMarkets
Tumor Ablation Market – Global Forecasts to 2019 MD 3271
SAMPLE TABLES TABLE 1
TUMOR ABLATION MARKET SIZE FOR SURGICAL ABLATION MODE OF TREATMENT, BY REGION, 2012-2019 ($MILLION) Technology
2012
2013
2014-e
CAGR%
2019-p
(2014-2019)
North America
XX
XX
XX
XX
XX
Europe
XX
XX
XX
XX
XX
Asia-Pacific
XX
XX
XX
XX
XX
RoW
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
Note: e= Estimated, p= Projected Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Articles, Expert Interviews, and MarketsandMarkets Analysis
TABLE 2
NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) Technology
2012
2013
2014-e
CAGR%
2019-p
(2014-2019)
Radiofrequency
XX
XX
XX
XX
XX
Microwave
XX
XX
XX
XX
XX
Cryoablation
XX
XX
XX
XX
XX
Others
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals Articles, Expert Interviews, and MarketsandMarkets Analysis
TABLE 3
NORTH AMERICA: TUMOR ABLATION PROCEDURE VOLUME, BY APPLICATION, 2012–2019 Technology
2012
2013
2014-e
CAGR%
2019-p
(2014-2019)
Liver Cancer
XX
XX
XX
XX
XX
Lung Cancer
XX
XX
XX
XX
XX
Kidney Cancer
XX
XX
XX
XX
XX
Bone Metastasis
XX
XX
XX
XX
XX
Others
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals Articles, Expert Interviews, and MarketsandMarkets Analysis
18 © MarketsandMarkets
Tumor Ablation Market â&#x20AC;&#x201C; Global Forecasts to 2019 MD 3271
1.5
RELATED REPORTS Report Title
Published Date
Ablation Technologies Market
1
By Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019
September, 2014
http://www.marketsandmarkets.com/MarketReports/ablation-devices-market-791.html
Electrosurgery Market
2
By Product - Generator, Electrosurgical Instruments (Vessel Sealing, Bipolar Forceps, Electrode, Suction Coagulator), Accessories, Surgery (General, Gynecology, Orthopedic, Cardiovascular, Cosmetic) - Global Forecasts to 2019
April, 2014
http://www.marketsandmarkets.com/MarketReports/electrosurgery-market-142006761.html
19 Š MarketsandMarkets
Tumor Ablation Market â&#x20AC;&#x201C; Global Forecasts to 2019 MD 3271
Disclaimer: MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customersâ&#x20AC;&#x2122; internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications. MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets' research and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited.
For information regarding permission, contact: Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com
20 Š MarketsandMarkets